Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-19

Clinical Trial Update: An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study [Phase 2]

View source ↗

Summary

Phase 2 open-label randomized crossover pharmacokinetics study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lupin Research Inc | Conditions: Pregnancy Prevention | Phase 2 | Status: COMPLETED